![Alan Bradley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan Bradley
Fondatore presso
Kymab Group Ltd.
Profilo
Allan Bradley is the founder of Spectral Genomics, Inc., founded in 2000.
Dr. Bradley is the founder of ExpressionEdits Ltd., founded in 2021.
Dr. Bradley is the founder of T-Therapeutics Ltd., founded in 2022, and holds the title Chief Scientific Officer & Director since 2025.
Dr. Bradley is also the founder of Lexicon Pharmaceuticals, Inc.,Kymab Group Ltd...
Dr. Bradley is an Independent Director at Sieger Healthcare Acquisition Corp.
Dr. Bradley is a Professor at the University of Cambridge.
Dr. Bradley was Executive Director at Wellcome Trust Sanger Institute.
Dr. Bradley was Professor at Baylor College of Medicine.
Dr. Bradley completed undergraduate, graduate, and doctorate degrees at the University of Cambridge.
Posizioni attive di Alan Bradley
| Società | Posizione | Inizio |
|---|---|---|
Sieger Healthcare Acquisition Corp.
 Sieger Healthcare Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Direttore/Membro del Consiglio | - |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Fondatore | - |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Precedenti posizioni note di Alan Bradley
| Società | Posizione | Fine |
|---|---|---|
ExpressionEdits Ltd.
 ExpressionEdits Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that redesigns transgenic instructions by AI-driven platform | Fondatore | - |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| LEXICON PHARMACEUTICALS, INC. | Fondatore | - |
Wellcome Trust Sanger Institute
 Wellcome Trust Sanger Institute BiotechnologyHealth Technology Provides genomic research services | Direttore/Membro del Consiglio | - |
Spectral Genomics, Inc.
 Spectral Genomics, Inc. BiotechnologyHealth Technology Develops DNA microarrays and chips used in cloning and genome profiling | Fondatore | - |
Formazione di Alan Bradley
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
76
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Lexicon Pharmaceuticals, Inc.
 Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spectral Genomics, Inc.
Spectral Genomics, Inc. BiotechnologyHealth Technology Develops DNA microarrays and chips used in cloning and genome profiling | Health Technology |
Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute BiotechnologyHealth Technology Provides genomic research services | Health Technology |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Health Technology |
Sieger Healthcare Acquisition Corp.
Sieger Healthcare Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
ExpressionEdits Ltd.
ExpressionEdits Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that redesigns transgenic instructions by AI-driven platform | Commercial Services |
